MMF, leflunomide, sulfasalazine, calcineurin inhibitors, and nonsteroidal antiinflammatory drugs (NSAIDs) Although the drug label suggests discontinuation of MTX before attempting pregnancy, data show no evidence for mutagenesis or teratogenicity Although sulfasalazine may affect sperm count and quality, there are no data suggesting teratogenicity We conditionally recommend continuation of anakinra and rituximab based on limited data Maternal medication use. Supplementary Appendix 7, Tables I